Afuco™ Anti-Human EPHA3 ADCC Therapeutic Antibody (KB004), ADCC Enhanced
Anti-EPHA3 ADCC Enhanced Antibody (KB004) is an ADCC enhanced antibody produced by our Afuco™ platform. KB004 is a first-in-class, monoclonal antibody targeting the EphA3 receptor tyrosine kinase. KB004 has the potential to attack tumors at their source by killing tumor stem cells, the tumor stromal cells that protect them, and the vasculature that feeds them. This unique activity provides the potential to generate durable responses by targeting the source of tumor cells. KB004 has been shown to be expressed in many tumor types, including hematologic malignancies and solid tumors.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-225CL |
| Pricing | Inquiry |
| Host | Chimeric (human/mouse) |
| Target | EPHA3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |